These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17582289)

  • 1. [Clinical implications of relationship between myeloperoxidase and acute coronary syndromes].
    Li SH; Xing YW; Li ZZ; Bai SG; Wang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Mar; 35(3):241-4. PubMed ID: 17582289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
    Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myeloperoxidase in the plasma of patients with acute coronary syndrome].
    Ouyang M; Yang K; Zhang MX; Jiang WH; Cao Y; Wang JG; Gao YD
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 31(6):901-5. PubMed ID: 17213593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum.
    Peacock WF; Nagurney J; Birkhahn R; Singer A; Shapiro N; Hollander J; Glynn T; Nowak R; Safdar B; Miller C; Peberdy M; Counselman F; Chandra A; Kosowsky J; Neuenschwander J; Schrock J; Plantholt S; Lewandrowski E; Wong V; Kupfer K; Diercks D
    Am Heart J; 2011 Nov; 162(5):893-9. PubMed ID: 22093206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-hospital free fatty acids levels predict the severity of myocardial ischemia of acute coronary syndrome.
    Ma P; Han L; Lv Z; Chen W; Hu H; Tu J; Zhou X; Liu SM
    BMC Cardiovasc Disord; 2016 Feb; 16():29. PubMed ID: 26830193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome.
    Cavusoglu E; Ruwende C; Eng C; Chopra V; Yanamadala S; Clark LT; Pinsky DJ; Marmur JD
    Am J Cardiol; 2007 May; 99(10):1364-8. PubMed ID: 17493461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active and total myeloperoxidase in coronary artery disease and relation to clinical instability.
    Gach O; Brogneaux C; Franck T; Serteyn D; Legrand V; Pierard LA; Magne J
    Acta Cardiol; 2015 Oct; 70(5):522-7. PubMed ID: 26567811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain.
    Nicholls SJ; Tang WH; Brennan D; Brennan ML; Mann S; Nissen SE; Hazen SL
    Clin Chem; 2011 Dec; 57(12):1762-70. PubMed ID: 21940659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
    Aminian A; Boudjeltia KZ; Babar S; Van Antwerpen P; Lefebvre P; Crasset V; Leone A; Ducobu J; Friart A; Vanhaeverbeek M
    Eur J Intern Med; 2009 Sep; 20(5):527-32. PubMed ID: 19712859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
    Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Schömig A; Kastrati A
    Eur J Clin Invest; 2008 Feb; 38(2):90-6. PubMed ID: 18226042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of neutrophil myeloperoxidase in coronary circulation among patients with acute coronary syndrome].
    Li L; Zhang Y; Chen YG; Li GS; Wang Y; Ma X; Li JF; Zhong M; Zhang W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1106-8. PubMed ID: 16563281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between fasting plasma glucose and MPO in patients with acute coronary syndrome.
    Zhang X; Dong L; Wang Q; Xie X
    BMC Cardiovasc Disord; 2015 Aug; 15():93. PubMed ID: 26307104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of myeloperoxidase in early diagnosis of acute myocardial infarction in patients admitted with chest pain.
    Omran MM; Zahran FM; Kadry M; Belal AAM; Emran TM
    J Immunoassay Immunochem; 2018; 39(3):337-347. PubMed ID: 29985768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of MPO plasma levels in patients admitted for suspected myocardial infarction.
    Rudolph V; Goldmann BU; Bös C; Rudolph TK; Klinke A; Friedrichs K; Lau D; Wegscheider K; Haddad M; Meinertz T; Baldus S
    Int J Cardiol; 2011 Dec; 153(3):267-71. PubMed ID: 20846733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.
    Baldus S; Heeschen C; Meinertz T; Zeiher AM; Eiserich JP; Münzel T; Simoons ML; Hamm CW;
    Circulation; 2003 Sep; 108(12):1440-5. PubMed ID: 12952835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum myeloperoxidase activities are significantly associated with the prevalence of ACS and High LDL-C levels in CHD patients.
    Liu C; Xie G; Huang W; Yang Y; Li P; Tu Z
    J Atheroscler Thromb; 2012; 19(5):435-43. PubMed ID: 22659527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between levels of serum growth differentiation factor-15 and acute coronary syndrome].
    Zheng LB; Guo YH; Yu HY; Mi L; Wang YP; Gao W
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):250-4. PubMed ID: 21503121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes.
    Liang J; Zheng Z; Wang M; Han L; Zheng Z; Peng J; Liu Z; Wei Y
    J Int Med Res; 2009; 37(3):862-6. PubMed ID: 19589271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of myeloperoxidase, white blood cell count and 3-chlorotyrosine in Taiwanese patients with acute myocardial infarction.
    Cheng ML; Chen CM; Gu PW; Ho HY; Chiu DT
    Clin Biochem; 2008 May; 41(7-8):554-60. PubMed ID: 18314009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjects with chest pain.
    Granér M; Tikkanen E; Rimpilä O; Tikkanen H; Ripatti S; Lokki ML; Nieminen MS; Taskinen MR; Sinisalo J
    Ann Med; 2013 Jun; 45(4):322-7. PubMed ID: 23651064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.